Metabolism-directed optimization of 3-aminopyrazinone acetamide thrombin inhibitors. Development of an orally bioavailable series containing P1 and P3 pyridines
CS Burgey, KA Robinson, TA Lyle…
文献索引：Journal of Medicinal Chemistry, , vol. 46, # 4 p. 461 - 473
